EML +31.54% The troubled payments company delivered an update today that was well ahead of company guidance into a market that was ~6% short, and fireworks ensued! Revenue of $254.2m was up 9% and ahead the $239m expected driving an underlying EBITDA beat of ~20%. They are making progress on their strategic review and operational turnaround which has seen the stocks lift itself from the depths of despair. We have management in tomorrow and will provide additional colour from there.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
Friday 30th May – Dow up +117pts, SPI down -17pts
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
Active Growth Portfolio – Showing Weighted Beta
Close
MM remains long EML in the Emerging Companies Portfolio
Add To Hit List
Related Q&A
What are your current thoughts on EML
Cutting losses in the Emerging Portfolio
Does MM believe EML is a buy?
Is MM considering EML at the moment?
Thoughts on Emeco (EHL) & Service Stream (SSM) please
Why did MM hold EML so long?
Does MM see merit in “Averaging Down”?
Does MM see trading Opportunities in ELO, EML or TYR?
MM thoughts on A2 Milk (A2M) & EML Payments (EML)
Relevant suggested news and content from the site

Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.

Podcast
LISTEN
Friday 30th May – Dow up +117pts, SPI down -17pts
Daily Podcast Direct from the Desk

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.


chart
Active Growth Portfolio – Showing Weighted Beta
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.